Sales and earnings growth in Q2 2015

“All three business sectors contributed to our good double-digit sales growth,” said Karl-Ludwig Kley, CEO. “We confirm our forecast for the full year 2015.”

Creating Bridges between Science and Literature

The French author Maylis de Kerangal and the American science writer David Quammen were each awarded the literature prize „Premio Letterario Merck“. The company promotes literature as part of its good corporate citizenship.

Growing presence – based on innovation

We are acquiring Qlight Nanotech Ltd., Jerusalem, Israel. “The acquisition of Qlight Nanotech perfectly fits into our innovation strategy as innovations are our lifeblood,” said Karl-Ludwig Kley, CEO and Chairman of the Executive Board of Merck KGaA, Darmstadt, Germany.

What`s the best way for our company to grow around the world - 125 Years in the U.S.

"We must clearly understand that ...the focus of our business will be here in America. America is the country of the future (and) will...supply the world market with many of the products from our industrie."
(Georg Merck)

Asco 2015 - Welcoming Collaboration, Driving Innovation

“We are eager to share the latest early data for avelumab at ASCO,” said Belén Garijo, Member of our executive Board and CEO Healthcare, “this is the first time we will be presenting data on avelumab as an alliance. And we are making good progress with our Evofosfamide drug candidate for the possible treatment of pancreatic cancer as well as soft tissue sarcoma.”

Global Strategic Alliance with Pfizer on Anti-PD-L1 to Accelerate Presence in Immuno-Oncology

November 17, 2014 – Merck KGaA, Darmstadt, Germany, and Pfizer entered into a global agreement to co-develop and co-commercialize our investigational anti-PD-L1 antibody as a potential treatment for multiple tumor types to accelerate the two companies’ presence in immuno-oncology.
As part of the agreement, Merck KGaA, Darmstadt, Germany, will co-promote Pfizer’s Xalkori, a medicine to treat non-small cell lung cancer, in the United States and several other key markets.

 

Media Services for the US and Canada – News starting 2013, Dates & Publications

Latest Press Releases
Merck KGaA, Darmstadt, Germany, Places Euro Bonds Amounting to € 2.1 Billion
Merck KGaA, Darmstadt, Germany, Places Euro Bonds Amounting to € 2.1 Billion
Darmstadt, Germany, August 27, 2015 – Merck KGaA, Darmstadt, Germany, successfully placed euro bonds today via Merck Financial Services GmbH, a subsidiary of Merck KGaA, Darmstadt, Germany. This serves the financing of the proposed acquisition of the U.S. life science company Sigma-Aldrich. 
 
Merck KGaA, Darmstadt, Germany, has selected three start-ups for the first round of its in-house Accelerator Program.
Participants for Merck KGaA, Darmstadt, Germany’s Accelerator Program Selected
Darmstadt, Germany, August 27, 2015 – Merck KGaA, Darmstadt, Germany, has selected three start-ups for the first round of its in-house Accelerator Program.
 
Merck KGaA, Darmstadt, Germany, Secures All Antitrust Approvals for Sigma-Aldrich Acquisition
Merck KGaA, Darmstadt, Germany, Secures All Antitrust Approvals for Sigma-Aldrich Acquisition
Darmstadt, Germany, August 11, 2015 – Merck KGaA, Darmstadt, Germany, today announced that approvals have been secured from all relevant jurisdictions for its planned acquisition of U.S.-based life science company Sigma-Aldrich.
 
 
top

OUR COMPANY IN THE MEDIA

OUR COMPANY IN THE MEDIA
Read how Merck KGaA, Darmstadt, Germany, and its affiliates are covered by media outlets around the world

DOWNLOAD LIBRARY

Download Library
Download images, Media Kits and other material from our media download library

CALENDAR OF EVENTS

Calendar of Events
Find and register for upcoming events

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
In the United States and Canada the subsidiaries of Merck KGaA, Darmstadt, Germany operate under the umbrella brand EMD. To reflect such fact and to avoid any misconception of the reader of the publication certain logos, terms and business descriptions of the publication have been substituted or additional descriptions have been added. Publications on this homepage, therefore, slightly deviate from the otherwise identical version of the publications provided outside the United States and Canada.
 

CONTACTS FOR JOURNALIST INQUIRIES

Media Team
POSTAL ADDRESS 
Merck KGaA 
Frankfurter Straße 250 
64293 Darmstadt 
Germany
Tel.: +49 6151 72-5000
Fax: +49 6151 72-3138
 

GENERAL INQUIRIES

Communications Center
Tel.: +49 6151 72-0
Fax: +49 6151 72-2000
 

FINANCIAL REPORT ON Q2 2015

Merck Financial Report
Merck on Facebook
Twitter
 
  
Read more on M - The Explorer Magazine

Active in spite of MS: To the top of the Andes

Yuval T. is suffering from multiple sclerosis. But he sets ambitious goals for himself, and attains them: He runs marathons and climbs the world’s highest peaks.

Read more on M - The Explorer Magazine
Read more on M - The Explorer Magazine

Forcing cancer to come out of hiding

Immuno-oncology focuses on harnessing a patient’s immune system to fight cancer. The body’s immune system naturally detects and destroys cancer cells.

Read more on M - The Explorer Magazine
Read more on M - The Explorer Magazine

“Innovation Boost” — a global forum for ideas

Intelligent people have pioneering ideas. But how can the world’s collective knowledge be brought together in one place? “Innovation Boost” used social media to meet this challenge.

Read more on M - The Explorer Magazine